US5474783A
(en)
*
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5633000A
(en)
*
|
1994-06-23 |
1997-05-27 |
Axxia Technologies |
Subcutaneous implant
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US6512010B1
(en)
*
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
ES2259746T3
(es)
*
|
1996-07-15 |
2006-10-16 |
Alza Corporation |
Nuevas formulaciones para la administracion transdermica de fluoxetina.
|
US6572880B2
(en)
|
1996-10-24 |
2003-06-03 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6290986B1
(en)
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
US5952000A
(en)
*
|
1996-10-30 |
1999-09-14 |
Theratech, Inc. |
Fatty acid esters of lactic acid salts as permeation enhancers
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
US5980898A
(en)
*
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
DE19706824C1
(de)
*
|
1997-02-21 |
1998-03-26 |
Lohmann Therapie Syst Lts |
Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften
|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
PT1510213E
(pt)
*
|
1997-11-10 |
2009-02-12 |
Strakan Internat Ltd Uma Socie |
Sistemas de melhoramento de penetração e reduzida irritação incluíndo testosterona
|
TW492882B
(en)
*
|
1997-11-28 |
2002-07-01 |
Caleb Pharmaceuticals Inc |
Cholinergic antagonist plaster composition
|
US20020102291A1
(en)
*
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US6210705B1
(en)
*
|
1997-12-15 |
2001-04-03 |
Noven Pharmaceuticals, Nc. |
Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
EP1459741A1
(en)
*
|
1997-12-15 |
2004-09-22 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with menthylphenidate
|
US6727401B1
(en)
*
|
1998-02-12 |
2004-04-27 |
Watson Pharmaceuticals, Inc. |
Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
|
DE29823343U1
(de)
*
|
1998-03-20 |
1999-07-15 |
Schwarz Pharma Ag, 40789 Monheim |
Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
|
DE19814084B4
(de)
*
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
US6475514B1
(en)
|
1998-12-03 |
2002-11-05 |
Andrew Blitzer |
Athletic patch
|
KR100383252B1
(ko)
*
|
1998-12-17 |
2003-07-16 |
주식회사 삼양사 |
부프레놀핀을함유하는경피투여조성물및이를포함하는패취
|
AU3536799A
(en)
*
|
1999-04-26 |
2000-11-10 |
Lead Chemical Co., Ltd. |
Percutaneous preparations containing oxybutynin
|
AU6403600A
(en)
*
|
1999-06-10 |
2001-01-02 |
Sepracor, Inc. |
Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin
|
DK1194109T3
(da)
|
1999-06-25 |
2004-10-25 |
Durham Pharmaceuticals Ltd |
Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf
|
GB9918735D0
(en)
*
|
1999-08-09 |
1999-10-13 |
Straken Limited |
Transdermal patches
|
US20010049546A1
(en)
*
|
2000-02-08 |
2001-12-06 |
Israel Dvoretzky |
Multi-purpose drug and heat therapy treatment system
|
US6436428B1
(en)
|
2000-03-21 |
2002-08-20 |
Enhance Pharmaceuticals, Inc. |
Device and method for treating urinary incontinence in females
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
CA2406064C
(en)
*
|
2000-04-26 |
2011-03-15 |
Watson Pharmaceuticals, Inc. |
Minimizing adverse experience associated with oxybutynin therapy
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
DE60127134T2
(de)
*
|
2000-08-03 |
2007-11-08 |
Antares Pharma Ipl Ag |
Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
|
DE10041478A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
DE10060550C1
(de)
*
|
2000-12-06 |
2002-04-18 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
|
US6585963B1
(en)
*
|
2001-02-15 |
2003-07-01 |
Watson Pharmaceuticals, Inc. |
Nail compositions and methods of administering same
|
US20030027793A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal treatment of parkinson's disease
|
US20030026830A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
ATE547095T1
(de)
*
|
2001-05-11 |
2012-03-15 |
Isis Pharmaceuticals Inc |
Antisense-permeationsverstärker
|
US6913760B2
(en)
*
|
2001-08-06 |
2005-07-05 |
New England Medical Hospitals, Inc. |
Drug delivery composition
|
AU2002340120A1
(en)
*
|
2001-10-04 |
2003-04-14 |
Cellegy Pharmaceuticals, Inc. |
Semisolid topical hormonal compositions and methods for treatment
|
US7921999B1
(en)
|
2001-12-20 |
2011-04-12 |
Watson Laboratories, Inc. |
Peelable pouch for transdermal patch and method for packaging
|
JP4295467B2
(ja)
*
|
2002-04-12 |
2009-07-15 |
日東電工株式会社 |
貼付剤およびその製造方法
|
KR100469995B1
(ko)
*
|
2002-05-20 |
2005-02-05 |
안국약품 주식회사 |
천식치료제를 함유한 매트릭스형 패취
|
JP4323138B2
(ja)
*
|
2002-06-05 |
2009-09-02 |
日東電工株式会社 |
経皮吸収型製剤およびその製造方法
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
EP1386604A1
(en)
*
|
2002-07-30 |
2004-02-04 |
Schwarz Pharma Ag |
Improved transdermal delivery system
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
US20040197397A1
(en)
*
|
2002-08-30 |
2004-10-07 |
Watson Pharmaceuticals, Inc. |
Drug delivery system for treatment of urinary incontinence
|
DE10251256A1
(de)
*
|
2002-11-04 |
2004-05-13 |
Novosis Ag |
Transdermales Wirkstoffabgabesystem für Oxybutynin
|
EP1426049B1
(en)
*
|
2002-12-02 |
2005-05-18 |
Schwarz Pharma Ag |
Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
|
DE10261696A1
(de)
*
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
AU2004233997C1
(en)
*
|
2003-04-29 |
2014-01-30 |
Massachusetts Institiute Of Technology |
Methods and devices for the sustained release of multiple drugs
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
PT1670433E
(pt)
|
2003-10-10 |
2012-02-08 |
Ferring Bv |
Fórmula farmacológica transdérmica para a minimização de resíduos na pele
|
WO2005077364A1
(ja)
*
|
2004-02-18 |
2005-08-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
ソリフェナシンの経皮投与製剤およびその経皮透過改善方法
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US8173155B2
(en)
*
|
2004-06-01 |
2012-05-08 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive patch
|
WO2006031856A2
(en)
|
2004-09-13 |
2006-03-23 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
US8252320B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
PL1814531T3
(pl)
|
2004-10-21 |
2010-11-30 |
Durect Corp |
Transdermalne systemy dostarczania
|
US20070053965A1
(en)
*
|
2005-02-25 |
2007-03-08 |
Gruenenthal Gmbh |
Kit comprising a plaster, optionally containing an active substance, and an agent that at least partially reduces skin irritation
|
WO2007124250A2
(en)
*
|
2006-04-21 |
2007-11-01 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
US8372040B2
(en)
|
2005-05-24 |
2013-02-12 |
Chrono Therapeutics, Inc. |
Portable drug delivery device including a detachable and replaceable administration or dosing element
|
US8067399B2
(en)
*
|
2005-05-27 |
2011-11-29 |
Antares Pharma Ipl Ag |
Method and apparatus for transdermal or transmucosal application of testosterone
|
US20070065494A1
(en)
*
|
2005-08-03 |
2007-03-22 |
Watson Laboratories, Inc. |
Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
|
US10137135B2
(en)
*
|
2005-08-15 |
2018-11-27 |
Allergan Sales, Llc |
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
|
JP5037831B2
(ja)
*
|
2006-02-15 |
2012-10-03 |
久光製薬株式会社 |
凝集力向上及び徐放化の外用貼付剤
|
CN101431988A
(zh)
*
|
2006-02-27 |
2009-05-13 |
诺芬药品公司 |
包含东莨菪碱的透皮治疗系统
|
US20070293582A1
(en)
*
|
2006-06-05 |
2007-12-20 |
Malcolm Hill |
Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
|
US20070293581A1
(en)
*
|
2006-06-05 |
2007-12-20 |
Malcolm Hill |
Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
US8889155B2
(en)
*
|
2006-12-28 |
2014-11-18 |
Kaken Pharmaceutical Co., Ltd. |
Gel composition for treating mycosis
|
NZ552816A
(en)
*
|
2007-01-24 |
2009-05-31 |
Bomac Research Ltd |
Formulation for transdermal administration of antihyperthyroid drug comprising a penetration enhancer selected from oleic acid, d-limonene, pyrrolidones, a C2-C8 alcohol, glycol ethers, triacetin and combinations thereof
|
EP2123274B1
(en)
|
2007-03-02 |
2016-08-24 |
Teika Pharmaceutical Co., Ltd. |
Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
|
US20080226698A1
(en)
|
2007-03-16 |
2008-09-18 |
Mylan Technologies, Inc. |
Amorphous drug transdermal systems, manufacturing methods, and stabilization
|
US10183001B1
(en)
*
|
2007-05-22 |
2019-01-22 |
Pisgah Laboratories, Inc. |
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
|
EP2182987A4
(en)
*
|
2007-07-30 |
2011-11-02 |
Medacure International Inc |
FORMULATION FOR IMMUNE SYSTEM MODULATOR
|
US20090098191A1
(en)
*
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
CA2708234C
(en)
*
|
2007-12-12 |
2015-11-24 |
Teikoku Seiyaku Co., Ltd. |
Aqueous loxoprofen-containing patches
|
US20090297591A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Orient Pharma Co., Ltd. |
Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
|
US8404255B2
(en)
*
|
2008-07-29 |
2013-03-26 |
Matt Gibson |
System and method for transdermal drug delivery
|
CN102209627B
(zh)
|
2008-10-02 |
2013-11-06 |
迈兰公司 |
多层粘合剂层压制品的制造方法
|
JP5155128B2
(ja)
*
|
2008-12-11 |
2013-02-27 |
日東電工株式会社 |
メチルフェニデート貼付製剤
|
US8920392B2
(en)
|
2009-05-05 |
2014-12-30 |
Watson Laboratories, Inc. |
Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
|
US8840922B2
(en)
*
|
2009-10-21 |
2014-09-23 |
Teikoku Seiyaku Co., Ltd. |
Transdermally absorbable donepezil-containing preparation
|
CN102740890B
(zh)
|
2009-12-15 |
2015-05-13 |
帝国制药株式会社 |
含碱性消炎镇痛药的经皮吸收制剂
|
EP2557924B1
(en)
|
2010-04-13 |
2019-06-12 |
Relmada Therapeutics, Inc. |
Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
|
JP5812500B2
(ja)
|
2010-04-30 |
2015-11-17 |
メルク・シャープ・エンド・ドーム・コーポレイション |
新規なβ3アドレナリン作動性受容体アゴニスト
|
FR2972923B1
(fr)
*
|
2011-03-25 |
2013-08-23 |
Urgo Lab |
Composition filmogene contenant un filtre solaire, son utilisation pour le traitement des cicatrices
|
US11786455B2
(en)
|
2011-05-10 |
2023-10-17 |
Itochu Chemical Frontier Corporation |
Non-aqueous patch
|
US9925264B2
(en)
|
2011-05-10 |
2018-03-27 |
Itochu Chemical Frontier Corporation |
Non-aqueous patch
|
US9283174B2
(en)
|
2011-05-10 |
2016-03-15 |
Tatsuya Mori |
Non-aqueous patch
|
CA2844367C
(en)
*
|
2011-06-24 |
2016-02-16 |
Acenda Pharma, Inc. |
Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
|
CA2841785A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
PL2823815T3
(pl)
|
2011-09-27 |
2018-10-31 |
Itochu Chemical Frontier Corporation |
Niewodny plaster
|
EP2772252B1
(en)
*
|
2011-10-26 |
2020-03-18 |
Hisamitsu Pharmaceutical Co., Inc. |
Oxybutynin-containing transdermal absorption preparation
|
US20130266643A1
(en)
*
|
2012-04-10 |
2013-10-10 |
Hpo Life Sciences, Inc. |
Compositions comprising glyceryl-triacetate (GTA) and uses in human performance optimization and thermogenesis
|
RU2665372C2
(ru)
*
|
2012-09-03 |
2018-08-29 |
Дайити Санкио Компани, Лимитед |
Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона
|
EP2897620B1
(en)
|
2012-09-21 |
2020-07-22 |
Intensity Therapeutics, Inc |
Method of treating cancer
|
US9072682B2
(en)
|
2012-12-31 |
2015-07-07 |
Mylan Inc. |
Transdermal dosage form for low-melting point active agent
|
CN103919754B
(zh)
*
|
2013-01-15 |
2018-11-06 |
江苏康倍得药业股份有限公司 |
奥昔布宁药物组合物及其应用
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
US20140271792A1
(en)
*
|
2013-03-14 |
2014-09-18 |
Noven Pharmaceuticals, Inc. |
Methylphenidate transdermal compositions with rubber-based adhesives
|
AU2015233880A1
(en)
*
|
2014-03-21 |
2016-10-06 |
Chironwells Gmbh |
6-(amino acid)-morphinan derivatives in combination with permeation enhancers for use as an orally, rectally, transdermally or nasally administered medicament
|
CA2973372A1
(en)
|
2015-01-09 |
2016-07-14 |
Chase Pharmaceuticals Corporation |
Oxybutynin transdermal therapeutic system combination
|
WO2016123406A1
(en)
|
2015-01-28 |
2016-08-04 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
US11285306B2
(en)
|
2017-01-06 |
2022-03-29 |
Morningside Venture Investments Limited |
Transdermal drug delivery devices and methods
|
JP2019034905A
(ja)
*
|
2017-08-17 |
2019-03-07 |
コスメディ製薬株式会社 |
デヒドロ酢酸含有経皮吸収製剤
|
EP3704123A1
(en)
*
|
2017-10-30 |
2020-09-09 |
Theracaine LLC |
Hydrophobic acid addition salts and pharmaceutical formulations thereof
|
KR101975677B1
(ko)
|
2017-11-20 |
2019-05-07 |
양진석 |
환편기용 보풀 제거장치
|
AU2019279884A1
(en)
|
2018-05-29 |
2020-12-10 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
WO2020085879A1
(ko)
|
2018-10-26 |
2020-04-30 |
경상대학교산학협력단 |
아세틴 화합물의 생물학적 제조 방법
|
CN113384558A
(zh)
*
|
2021-02-01 |
2021-09-14 |
深圳普洛美康材料有限公司 |
一种递送大麻活性物质的透皮贴剂
|
JP2022122784A
(ja)
|
2021-02-10 |
2022-08-23 |
コスメディ製薬株式会社 |
酸化防止剤含有経皮吸収製剤
|
KR20230026232A
(ko)
|
2021-08-17 |
2023-02-24 |
신신제약 주식회사 |
옥시부티닌을 함유하는 경피흡수제제
|
CN113749968A
(zh)
*
|
2021-10-26 |
2021-12-07 |
奥易生物科技(杭州)有限公司 |
一种快速透皮吸收的化妆品及其制备方法
|